2016
DOI: 10.1093/rheumatology/kew336
|View full text |Cite
|
Sign up to set email alerts
|

Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression

Abstract: This is the first study to report that the balance of two miRNAs is involved in the collagen dysregulation in SSc fibroblasts. Clarification of the regulatory mechanism of tissue fibrosis by IL-23 in SSc skin may lead to a better understanding of this disease and new therapeutic approaches.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(15 citation statements)
references
References 29 publications
1
13
0
1
Order By: Relevance
“…Meanwhile, the conventional hallmark of fibrosis is characterized by the accumulation of various fibrillar collagens, which principally serve as a marker of fibrosis, especially of Collagen 1 [24]. More notably, previous studies have demonstrated that miR-18a can diminish the expression of Collagen 1 via interleukin-23 [25]. Further in line with our findings, Yang et al [26] demonstrated that the involvement of miR-18a in the signaling pathway of TGF-β1 by mediation of CCN2.…”
Section: Discussionsupporting
confidence: 87%
“…Meanwhile, the conventional hallmark of fibrosis is characterized by the accumulation of various fibrillar collagens, which principally serve as a marker of fibrosis, especially of Collagen 1 [24]. More notably, previous studies have demonstrated that miR-18a can diminish the expression of Collagen 1 via interleukin-23 [25]. Further in line with our findings, Yang et al [26] demonstrated that the involvement of miR-18a in the signaling pathway of TGF-β1 by mediation of CCN2.…”
Section: Discussionsupporting
confidence: 87%
“…The evidence that enthesopathy in SSc and SpA shares the same micro-anatomical involvement and features suggests a possible common pathogenetic cascade across these two different diseases. In SSc, it has been shown that IL-23 and IL-17 up-regulate collagen production in fibroblasts, a process that could be significantly reduced by an IL-17-blocking antibody [25,26]. On this basis, it can be speculated that an altered IL-23/IL-17 axis might play a role also in SScrelated enthesopathy.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to AS, IL-23 is also involved in the pathogenesis of several other autoimmune diseases, such as inflammatory bowel disease and psoriasis, which all belong to the category of spondyloarthritis [ 21 ]. However, few studies have addressed the possible effect of IL-23 on the regulation of miRNA expression [ 22 24 ]. In this study, K562 cells instead of Jurkat cells were used as a platform for screening the IL-23-regulated miRNA expression because Jurkat cells had low expression levels of IL-23 receptor compared with K562 cells [ 12 ].…”
Section: Discussionmentioning
confidence: 99%